RJ4-21017-55136
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 503 / IA
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Dose 1 — Moderna
-
2020-12-27
Registered in v-safe
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-07
- 2021-01-14
- 2021-01-21
-
2021-01-27
Dose 2 — Moderna
- 2021-02-04
- 2021-02-10
- 2021-02-24
- 2021-03-03
- 2021-03-10
-
2021-04-28
Survey response — 3 months, dose 2MedDRA: Panniculitis, Uveitis — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: PanuveiitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-02
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Uveitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: UveitisMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-30
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Moderna | |
| 2 | 2021-01-27 | Moderna |
Call center
2 call center cases
2 unsuccessful
Free text
Release 8 — 3 months, dose 2
Symptoms: Panuveiitis
Release 9 — 6 months, dose 2
Symptoms: Uveitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Panniculitis | ○ | ✓ | ○ |
| SD | Uveitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release